Literature DB >> 19124028

Identification and functional analysis of a novel TRPC6 mutation associated with late onset familial focal segmental glomerulosclerosis in Chinese patients.

Bin Zhu1, Nan Chen, Zhao-Hui Wang, Xiao-Xia Pan, Hong Ren, Wen Zhang, Wei-Ming Wang.   

Abstract

OBJECTIVE: Mutations in the TRPC6 gene are responsible for a late onset form of familial focal segmental glomerulosclerosis (FSGS). However, the role of TRPC6 variation in Chinese patients with late onset familial FSGS remains unclear. Here, we screened 31 Chinese pedigrees with late onset familial FSGS for changes in TRPC6 by DNA sequence analysis.
METHODS: Genomic DNA was extracted from peripheral leukocytes. We PCR-amplified each of 13 exons of TRPC6 for sequence analysis. When a novel nucleotide change seemed likely to cause FSGS, we carried out an in vitro research to determine the effects of the mutation on TRPC6 function. HEK 293 cells were transfected stably with vectors containing mutant or wild type TRPC6 cDNA. We then compared the expression of mutant TRPC6 to wild type TRPC6 using Western blot. For the observation of the function of mutant TRPC6 channel compared with wild type TRPC6 channel, Intracellular Ca(2+) concentration was detected using fluorescent indicator Fluo-3 among different groups of cells upon stimulation with 1-oleoyl-2-acetyl sn-glycerol (OAG).
RESULTS: All the 31 pedigrees with late onset familial FSGS were collected in our department from September 1997 to October 2007. A novel TRPC6 mutation (cytosine 2664 adenine resulting in Glutamine 889 Lysine substitution, Q889K) was identified in one of these pedigrees. Mutant TRPC6 (TRPC6(Q889K)) or wild type TRPC6 was stably expressed in HEK293 cells by Western blot. The mutant TRPC6 expression was a little increased without significant difference compared with wild type TRPC6 expression, whereas the intracellular Ca(2+) level in cells expressing mutant TRPC6 was significantly increased compared with that in the cells expressing wild TRPC6 upon stimulation.
CONCLUSION: We identified a novel TRPC6 mutation Q889K associated with late onset FFSGS in Chinese pedigrees and this mutation was demonstrated to be "gain of function" by an in vitro functional research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19124028     DOI: 10.1016/j.mrfmmm.2008.11.021

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  30 in total

Review 1.  Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis.

Authors:  Jian Liu; Weiming Wang
Journal:  Front Med       Date:  2017-08-03       Impact factor: 4.592

2.  Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.

Authors:  Tom Nijenhuis; Alexis J Sloan; Joost G J Hoenderop; Jan Flesche; Harry van Goor; Andreas D Kistler; Marinka Bakker; Rene J M Bindels; Rudolf A de Boer; Clemens C Möller; Inge Hamming; Gerjan Navis; Jack F M Wetzels; Jo H M Berden; Jochen Reiser; Christian Faul; Johan van der Vlag
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

Review 3.  Transient receptor potential channelopathies.

Authors:  Bernd Nilius; Grzegorz Owsianik
Journal:  Pflugers Arch       Date:  2010-02-04       Impact factor: 3.657

4.  Novel mutations in the inverted formin 2 gene of Chinese families contribute to focal segmental glomerulosclerosis.

Authors:  Jingyuan Xie; Xu Hao; Evren U Azeloglu; Hong Ren; Zhaohui Wang; Jun Ma; Jian Liu; Xiaodan Ma; Weiming Wang; Xiaoxia Pan; Wen Zhang; Fang Zhong; Yifu Li; Guoyu Meng; Krzysztof Kiryluk; John Cijiang He; Ali G Gharavi; Nan Chen
Journal:  Kidney Int       Date:  2015-06-03       Impact factor: 10.612

5.  Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol.

Authors:  Nicole Urban; Sonja Neuser; Anika Hentschel; Sebastian Köhling; Jörg Rademann; Michael Schaefer
Journal:  Br J Pharmacol       Date:  2017-10-15       Impact factor: 8.739

Review 6.  Role of TRPC6 in Progression of Diabetic Kidney Disease.

Authors:  Alexander Staruschenko; Denisha Spires; Oleg Palygin
Journal:  Curr Hypertens Rep       Date:  2019-05-21       Impact factor: 5.369

7.  Structure of the receptor-activated human TRPC6 and TRPC3 ion channels.

Authors:  Qinglin Tang; Wenjun Guo; Li Zheng; Jing-Xiang Wu; Meng Liu; Xindi Zhou; Xiaolin Zhang; Lei Chen
Journal:  Cell Res       Date:  2018-04-26       Impact factor: 25.617

8.  Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome.

Authors:  Sheila Santín; Gemma Bullich; Bárbara Tazón-Vega; Rafael García-Maset; Isabel Giménez; Irene Silva; Patricia Ruíz; José Ballarín; Roser Torra; Elisabet Ars
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-17       Impact factor: 8.237

9.  Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Ashley C Johnson; Lateia Taylor; Cassandra Stubbs; Alyssa Nichols; Denise C Cornelius; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2020-02-18

10.  A novel TRPC6 mutation that causes childhood FSGS.

Authors:  Saskia F Heeringa; Clemens C Möller; Jianyang Du; Lixia Yue; Bernward Hinkes; Gil Chernin; Christopher N Vlangos; Peter F Hoyer; Jochen Reiser; Friedhelm Hildebrandt
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.